← Evidence map

ArticleCancers2025

Neutrophil to Lymphocyte Ratio as a Biomarker for the Prediction of Cancer Outcomes and Immune-Related Adverse Events in a CTLA-4-Treated Population.

Michael M Cunningham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Neutrophil to Lymphocyte Ratio as a Biomarker for the Prediction of Cancer Outcomes and Immune-Related Adverse Events in a CTLA-4-Treated Population. | OpenQuestion